Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 1/20 | 0.30 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.30 |
| ▸ | ITGB6 | P18564 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29870058 | 0.90 | — | — | |
| SCHEMBL28505446 | 0.68 | ITGAV (0.36) | ITGAVITGA5ITGB6 | |
| SCHEMBL28502141 | 0.60 | ITGAV (0.36) | ITGAVITGA5ITGB6 | |
| SCHEMBL29461158 | 0.58 | ITGAV (0.33) | ITGAVITGB6 | |
| SCHEMBL21953899 | 0.58 | ITGAV (0.56) | ITGAVITGA5ITGB6 | |
| SCHEMBL22893672 | 0.55 | ITGAV (0.58) | ITGAVITGB6 | |
| SCHEMBL29416481 | 0.54 | ITGAV (0.56) | ITGAVITGB6 | |
| SCHEMBL22893606 | 0.54 | ITGAV (0.56) | ITGAVITGB6 | |
| SCHEMBL21328584 | 0.52 | ITGAV (0.60) | ITGAVITGB6 | |
| SCHEMBL23544602 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11419869-B2 | Dosage forms and regimens for amino acid compounds | PLIANT THERAPEUTICS, INC. (US) | 2022-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11419869-B2 | Dosage forms and regimens for amino acid compounds | ITGB6, ITGA6, ITGAV | ITGAV 3/4885ITGA5 4/4885ITGB6 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.